SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-005971
Filing Date
2023-12-21
Accepted
2023-12-21 16:30:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 WEREWOLF THERAPEUTICS, INC. p23-2991sc13g.htm SC 13G 99004
  Complete submission text file 0000902664-23-005971.txt   100709
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Subject) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92515 | Film No.: 231505712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)